During continuous ambulatory peritoneal dialysis, the peritoneum is exposed to bioincompatible dialysis fluids that cause denudation of mesothelial cells and, ultimately, tissue fibrosis and failure ...
Continuous ambulatory peritoneal dialysis (CAPD) has been used as a renal replacement therapy in end-stage renal disease (ESRD) patients, along with hemodialysis. 1 However, after long-term treatment ...